GYPSY TEARS

Welcome to the Brand page for “GYPSY TEARS”, which is offered here for Plant extracts for pharmaceutical purposes, for the treatment of nausea, anxiety, pain, glaucoma, seizures, multiple sclerosis and crohn's disease; to the extent any of the foregoing involves cannabis, such cannabis shall have a delta-9 thc concentration of not more than 0.3% on a dry weight basis;electronic cigarette liquid comprised of essential oils; to the extent any of the foregoing involves use of cannabis, such cannabis shall have a delta-9 thc concentration of not more than 0.3% on a dry weight basis;electronic cigarette liquids comprised of flavoring in liquid form, other than essential oils, used to refill electronic cigarette cartridges; smoking pipes; smoking pipe cleaners; electronic smoking pipes; oral vaporizers for smokers; to the extent any of the foregoing involves use of cannabis, such cannabis shall have a delta-9 thc concentration of not more than 0.3% on a dry weight basis;.

Its status is currently believed to be active. Its class is unavailable. “GYPSY TEARS” is believed to be currently owned by “Trucenta Holdings LLC”.